Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment

Conclusion: Mood and substance use comorbidity is prevalent among patients seeking primary care office-based buprenorphine/naloxone treatment. The findings support the need for clinicians to assess and address these conditions. (Source: Drug and Alcohol Dependence)